Staphylococcal scalded skin syndrome in an older infant

Main Article Content

Ricardo Hernandez Sarmiento, Dr.
Maria Isabel Lozano Jaramillo, Dra.
Martha Isabel Alvarez Olmos, Dra.

Abstract

Background: Staphylococcal scalded skin syndrome (SSSS) is a rare condition, characterized by skin sputtering resulting from the action of exfoliative toxins (ET) produced by Staphylococcus aureus. The therapy consists on specific antibiotics and supportive treatment with interdisciplinary management.
Clinical case: We present the case of an older infant admitted with bullous lesions and skin disruption of short evolution that begins in the genital region, with progression and compromise of 40% of total body surface requiring management in the pediatric intensive care unit (PICU).
Conclusion: SSSS despite being an infrequent disease, presents a characteristic clinical feature that allows pediatricians to differentiate it from other infectious pathologies of the skin, and thus make an early diagnosis.

Downloads

Download data is not yet available.

Article Details

How to Cite
Hernandez Sarmiento, R., Lozano Jaramillo, M. I., & Alvarez Olmos, M. I. (2019). Staphylococcal scalded skin syndrome in an older infant. Pediatría, 52(1), 15–18. https://doi.org/10.14295/p.v52i1.129
Section
Case report

References

1. Mockenhaupt M, Idzko M, Grosber M, Schöpf E, Norgauer J. Epidemiology of staphylococcal scalded skin syndrome in Germany. J Invest Dermatol. 2005;124(4):700–3.

2. Staiman A, Hsu D, Silverberg J. Epidemiology of Staphylococcal Scalded Skin Syndrome in United Stated Children. Br J Dermatol. 2018;178(3):704–8.

3. Stanley JR, Amagai M. Pemphigus, Bullous Impetigo, and the Staphylococcal Scalded-Skin Syndrome. N Engl J Med. 2006;355(17):1800–10.

4. Handler MZ, Schwartz RA. Staphylococcal scalded skin syndrome: diagnosis and management in children and adults. J Eur Acad Dermatology Venereol. 2014;28(11):1418–23.

5. Kouakou K, Dainguy ME, Kassi K. Staphylococcal Scalded Skin Syndrome in Neonate. Case Rep Dermatol Med. 2015;2015:1–4.

6. Yamasaki O, Yamaguchi T, Sugai M, Chapuis-Cellier C, Arnaud F, Vandenesch F, et al. Clinical manifestations of staphylococcal scalded-skin syndrome depend on serotypes of exfoliative toxins. J Clin Microbiol. 2005;43(4):1890–3.

7. Dancer SJ, Garratt R, Saldanha J, Jhoti H, Evans R. The epidermolytic toxins are serine proteases. FEBS Lett. 1990;268(1):129–32.

8. Mishra AK, Yadav P, Mishra A. A Systemic Review on Staphylococcal Scalded Skin Syndrome (SSSS): A Rare and Critical Disease of Neonates. Open Microbiol J. 2016;10(1):150–9.

9. Amagai M, Matsuyoshi N, Wang ZH, Andl C, Stanley JR. Toxin in bullous impetigo and staphylococcal scalded-skin syndrome targets desmoglein 1. Nat Med. 2000;6(11):1275–7.

10. Amagai M, Yamaguchi T, Hanakawa Y, Nishifuji K, Sugai M, Stanley JR. Staphylococcal exfoliative toxin B specifically cleaves desmoglein 1. J Invest Dermatol. 2002;118(5):845–50.

11. Ladhani S. Recent developments in staphylococcal scalded skin syndrome. Clin Microbiol Infect. 2001;7(6):301–7.

12. Grama A, Mărginean OC, Meliț LE, Georgescu AM. Staphylococcal Scalded Skin Syndrome in Child. A Case Report and a Review from Literature. J Crit Care Med. 2016;2(4):192–7.

13. Blyth M, Estela C, Young AER. Severe staphylococcal scalded skin syndrome in children. Burns. 2008;34(1):98–103.

14. Gil F, Herranz M, Durán G, Zandueta I, Gimeno J, Bernaola E. Clindamicina como terapia adyuvante en el síndrome de piel escaldada estafilocócica. An Sist Sanit Navar. 2014;37(3):580–7.

15. Braunstein I, Wanat KA, Abuabara K, McGowan KL, Yan AC, Treat JR. Antibiotic sensitivity and resistance patterns in pediatric staphylococcal scalded skin syndrome. Pediatr Dermatol. 2014;31(3):305–8.

Most read articles by the same author(s)

Similar Articles

<< < 4 5 6 7 8 9 10 11 12 > >> 

You may also start an advanced similarity search for this article.